696.    Amersi FF, Terando AM, Goto Y, Scolyer RA, Thompson JF, Tran AN, Faries MB, Morton DL, Hoon DS: Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res 2008;14:638-645.

697.    Beavis A, Dawson M, Doble P, Scolyer RA, Bourne R, Li LX, Murali R, Stretch JR, Lean CL, Uren RF, Thompson JF: Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry. Ann Surg Oncol 2008;15:934-940.

698.    Chen JY, Hruby G, Scolyer RA, Murali R, Hong A, Fitzgerald P, Pham TT, Quinn MJ, Thompson JF: Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases. Cancer 2008.

699.    Cochran AJ, Thompson JF: Lymphatic mapping and sentinel node biopsy: The data unclouded by speculation. Arch Dermatol 2008;144:687-688.

700.    Collinson FJ, Lam TK, Bruijn WM, de Wilt JH, Lamont M, Thompson JF, Kefford RF: Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy. Ann Surg Oncol 2008;15:1741-1749.

701.    Doubrovsky A, Scolyer RA, Murali R, McKenzie PR, Watson GF, Lee CS, McLeod DJ, McCarthy WH, Uren RF, Stretch JR, Saw RP, Thompson JF: Diagnostic accuracy of fine needle biopsy for metastatic melanoma and its implications for patient management. Ann Surg Oncol 2008;15:323-332.

702.    Francken AB, Accortt NA, Shaw HM, Colman MH, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF: Follow-up schedules after treatment for malignant melanoma. Br J Surg 2008;95:1401-1407.

703.    Francken AB, Accortt NA, Shaw HM, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF: Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Ann Surg Oncol 2008;15:1476-1484.

704.    Francken AB, Shaw HM, Thompson JF: Detection of second primary cutaneous melanomas. Eur J Surg Oncol 2008;34:587-592.

705.    Francken AB, Thompson JF, Bastiaannet E, Hoekstra HJ: [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd 2008;152:557-562.

706.    Gallagher SJ, Thompson JF, Indsto J, Scurr LL, Lett M, Gao BF, Dunleavey R, Mann GJ, Kefford RF, Rizos H: p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors. Neoplasia 2008;10:1231-1239.

707.    Gershenwald JE, Uren R, Mariani G, Thompson JF: Sentinel lymph node biopsy in melanoma. in Mariani G, Giuliano AE, Strauss H (eds): Radioguided Surgery.  New York: Springer, 2008, 92-110.

708.    Haferkamp S, Becker TM, Scurr LL, Kefford RF, Rizos H: p16INK4a-induced senescence is disabled by melanoma-associated mutations. Aging Cell 2008;7:733-745.

709.    Ho Shon IA, Chung DK, Saw RP, Thompson JF: Imaging in cutaneous melanoma. Nucl Med Commun 2008;29:847-876.

710.    Ho Shon IA, Chung DK, Saw RP, Thompson JF: Guidelines for imaging in cutaneous melanoma. Nucl Med Commun 2008;29:877-879.

711.    Kam PC, Thompson JF: Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma. Surg Oncol Clin N Am 2008;17:795-804.

712.    Karim RZ, Scolyer RA, Li W, Yee VS, McKinnon JG, Li LX, Uren RF, Lam S, Beavis A, Dawson M, Doble P, Hoon DS, Thompson JF: False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology. Ann Surg 2008;247:1003-1010.

713.    Karim RZ, van den Berg KS, Colman MH, McCarthy SW, Thompson JF, Scolyer RA: The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology 2008;52:130-138.

714.    Kasparian NA, Butow PN, Meiser B, Mann GJ: High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective. Psychooncology 2008;17:270-279.

715.    Kroon HM, Moncrieff M, Kam PC, Thompson JF: Outcomes following isolated limb infusion for melanoma. A 14-year experience. Ann Surg Oncol 2008;15:3003-3013.

716.    Moncrieff M, Martin R, O'Brien CJ, Shannon KF, Clark JR, Gao K, Thompson JF: Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: Is there any benefit for high-risk patients? Ann Surg Oncol 2008;15:3022-3027.

717.    Moncrieff M, Scolyer R, Thompson J, Beavis A, Uren R, Stretch J: Correct identification of a sentinel node postselective lymphadenectomy using antimony levels. Melanoma Res 2008;18:365-366.

718.    Moncrieff M, Shannon K, Hong A, Hersey P, Thompson J: Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy. Melanoma Res 2008;18:161-162.

719.    Moncrieff MD, Bowen F, Thompson JF, Saw RP, Shannon KF, Spillane AJ, Quinn MJ, Stretch JR: Keystone flap reconstruction of primary melanoma excision defects of the leg-the end of the skin graft? Ann Surg Oncol 2008;15:2867-2873.

720.    Moncrieff MD, Kroon HM, Kam PC, Stalley PD, Scolyer RA, Thompson JF: Isolated limb infusion for advanced soft tissue sarcoma of the extremity. Ann Surg Oncol 2008;15:2749-2756.

721.    Moncrieff MD, Martin R, O'Brien CJ, Shannon KF, Clark JR, Gao K, McCarthy WM, Thompson JF: Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients? Ann Surg Oncol 2008;15:3022-3027.

722.    Morton DL, Cochran AJ, Thompson JF: The rationale for sentinel-node biopsy in primary melanoma. Nat Clin Pract Oncol 2008;5:510-511.

723.    Murali R, Loughman NT, McKenzie PR, Watson GF, Thompson JF, Scolyer RA: Cytologic Features of Metastatic and Recurrent Melanoma in Patients With Primary Cutaneous Desmoplastic Melanoma. Am J Clin Pathol 2008;130:715-723.

724.    Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, Scolyer RA: Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol 2008;15:302-309.

725.    Murali R, Thompson JF, Scolyer RA: Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. Future Oncol 2008;4:535-551.

726.    Murali R, Thompson JF, Scolyer RA: Fine-needle biopsy as a diagnostic technique for metastatic melanoma. Expert Opin Med Diagn 2008;2:1-10.

727.    Murali R, Thompson JF, Shaw HM, Scolyer RA: The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients. Am J Surg Pathol 2008;32:1106-1107; author reply 1107-1108.

728.    Sassen S, Shaw HM, Colman MH, Scolyer RA, Thompson JF: The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center. Ann Surg Oncol 2008;15:630-637.

729.    Scolyer RA, Murali R, McCarthy SW, Thompson JF: Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diag Pathol 2008;25:100-111.

730.    Scolyer RA, Murali R, Satzger I, Thompson JF: The detection and significance of melanoma micrometastases in sentinel nodes. Surg Oncol 2008;17:165-174.

731.    Shaw HM, Scolyer RA, Thompson JF: Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology 2008.

732.    Skalicky SE, Holt PE, Giblin M, Taylor S, Conway RM: Australian Cancer Network clinical practice guidelines for the management of ocular and periocular melanoma: an evidence-based literature analysis. Clin Experiment Ophthalmol 2008;36:646-658.

733.    Spillane AJ, Saw RP, Tucker M, Byth K, Thompson JF: Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg 2008;248:286-293.

734.    Thompson JF: The value of sentinel node biopsy in patients with primary cutaneous melanoma. Dermatol Surg 2008;34:550-554; discussion 554-555.

735.    Thompson JF: Commentary on the Pro/Con Articles in Clinical advances in Haematology and Oncology. InLondon, United Kingdom Melanoma Study Group, 2008:Website article.

736.    Thompson JF, Hersey P, Wachter E: Chemoablation of metastatic melanoma using intralesional Rose Bengal. Melanoma Res 2008;18:405-411.

737.    Thompson JF, Kam PC: Current status of isolated limb infusion with mild hyperthermia for melanoma. Int J Hyperthermia 2008;24:219-225.

738.    Van Es SL, Colman M, Thompson JF, McCarthy SW, Scolyer RA: Angiotropism is an independent predictor of local recurrence and in-transit metastasis in primary cutaneous melanoma. Am J Surg Pathol 2008;32:1396-1403.

739.    Warner RE, Quinn MJ, Hruby G, Scolyer RA, Uren RF, Thompson JF: Management of merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol 2008;15:2509-2518.

740.    Wiener M, Damian DL, Thompson JF: Systemic Phototoxicity following Intralesional Rose Bengal for Subcutaneous Melanoma Metastases. Dermatology 2008;216:361-362.